Incentives for global public health : patent law and access to essential medicines

The Resource Incentives for global public health : patent law and access to essential medicines

Label

Incentives for global public health : patent law and access to essential medicines

Title remainder

patent law and access to essential medicines

Statement of responsibility

edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein

Language

eng

Summary

This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of 'creative capitalism'.--

Assigning source

Provided by publisher

Cataloging source

UkCbUP

Index

index present

Literary form

non fiction

Nature of contents

dictionaries

Series statement

Connecting international law with public law
Cambridge Social Sciences eBooks

Context

Context of Incentives for global public health : patent law and access to essential medicines

Structured data from the Bibframe namespace is licensed under the Creative Commons Attribution 4.0 International License by European University Institute. Additional terms may apply to data associated with third party namespaces.

Context

Work of